Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 13

Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice

Total article views   HTML views PDF downloads Totals
8,536 Dovepress* 7,261+ 1,402 8,663
PubMed Central* 1,275 288 1,563
Totals 8,536 1,690 10,226
*Since 17 March 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar